| This Week’s News | Whole-body PET/CT with the standard radiotracer 18F-FDG is a dependable screening tool for catching many metastases, distant as well as regional lymphatic, according to researchers at the University of Minnesota. Whole-body PET/CT with the standard radiotracer 18F-FDG is a dependable screening tool for catching many metastases, distant as well as regional lymphatic, according to researchers at the University of Minnesota. | |
| Once a child’s broken arm is on the mend, little to nothing is gained by having follow-up x-rays read by both radiologists and orthopedic surgeons, according to a study conducted at Case Western Reserve University and published online March 6 in the Journal of Pediatric Orthopaedics. Once a child’s broken arm is on the mend, little to nothing is gained by having follow-up x-rays read by both radiologists and orthopedic surgeons, according to a study conducted at Case Western Reserve University and published online March 6 in the Journal of Pediatric Orthopaedics. | |
| To cut respiratory motion artifacts on liver MRI, have patients hold their breath at the end of an exhale rather at the end of an inhale. That’s the recommendation of Stanford researchers after testing and comparing the two techniques, and it holds for unenhanced and contrast-enhanced scans. To cut respiratory motion artifacts on liver MRI, have patients hold their breath at the end of an exhale rather at the end of an inhale. That’s the recommendation of Stanford researchers after testing and comparing the two techniques, and it holds for unenhanced and contrast-enhanced scans. | |
| Norman E. Sharpless, MD, director of the National Cancer Institute (NCI) since October 2017, has been announced as the new acting commissioner of the FDA. Sharpless replaces Scott Gottlieb, MD, who unexpectedly resigned from the position on March 5. Norman E. Sharpless, MD, director of the National Cancer Institute (NCI) since October 2017, has been announced as the new acting commissioner of the FDA. Sharpless replaces Scott Gottlieb, MD, who unexpectedly resigned from the position on March 5. | |
| | Gadolinium-based contrast agents (GBCAs) are typically administered during follow-up imaging of multiple sclerosis (MS) patients. According to new research published in Radiology, however, unenhanced MRI scans are sufficient. Gadolinium-based contrast agents (GBCAs) are typically administered during follow-up imaging of multiple sclerosis (MS) patients. According to new research published in Radiology, however, unenhanced MRI scans are sufficient. | |
| Follow-up imaging adherence rates vary based on a number of factors, according to new research published in the American Journal of Roentgenology. The authors noted that closely monitoring such patterns can help providers engage patients and minimize risk. Follow-up imaging adherence rates vary based on a number of factors, according to new research published in the American Journal of Roentgenology. The authors noted that closely monitoring such patterns can help providers engage patients and minimize risk. | |
| |
|
| | |
|